Founded on groundbreaking technology to game change the fight against antimicrobial resistance, Trobix Bio is expanding its vision to empower engineered phages with CRISPR to develop precision microbiome-based therapeutics that address huge unmet needs in major medical therapeutic areas
Location: Israel, Tel Aviv District, Tel Aviv-Yafo
Employees: 1-10
Total raised: $3M
Founded date: 2018
Funding Rounds 1
| Date | Series | Amount | Investors |
| 31.03.2023 | - | $3M | - |
Mentions in press and media 2
| Date | Title | Description | Source |
| 31.03.2023 | Israel-based Trobix Bio raises USD 3 million in funding | Netanya, an Israel-based biotechnology company developing microbiome oncology therapeutics, Trobix B... | vcbay.news... |
| 30.03.2023 | Trobix Bio Raises $3M in Equity Funding | Trobix Bio, a Netanya, Israel-based biotechnology company developing microbiome oncology therapeutic... | finsmes.co... |